Skip to content
No picture yet

Evrysdi 5 mg – DIN 02560747

Evrysdi is Risdiplam 5 mg (tablet), sold in Canada. It is used for spinal muscular atrophy. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Risdiplam 5 mg

Brand
Evrysdi
Strength
5 mg
Used for
Spinal muscular atrophy
Form
Tablet
Manufacturer
Hoffmann-LA Roche Limited
Drug class
Survival of motor neuron 2 splicing modifier
Sold in
Canada
DIN
02560747

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Risdiplam pills and guides

What is Risdiplam used for?

Risdiplam is used for spinal muscular atrophy.

Medicine type
Survival of motor neuron 2 splicing modifier
Official uses from the US prescribing label

EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

From the FDA-approved label on DailyMed (published Sep 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02560747.
  • It names Evrysdi, Risdiplam 5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Evrysdi by Hoffmann-LA Roche Limited.

In Canada: prescription only.

Ingredients

Active: Risdiplam

Other Risdiplam pills